dc.date.accessioned | 2022-03-07T17:57:33Z | |
dc.date.available | 2022-03-07T17:57:33Z | |
dc.date.created | 2022-02-06T13:01:24Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Fernández de Larrea, Carlos Kyle, RA Rosiñol, Laura Paiva, Bruno Engelhardt, Monika Usmani, Saad Caers, Jo Gonsalves, Wilson Schjesvold, Fredrik Hellem Merlini, Giampaolo Lentzch, Suzanne Ocio, Enrique Garderet, Laurent Moreau, Philippe Sonneveld, Pieter Badros, Ashraf Gahrton, Gösta Goldschmidt, Hartmut Tuchman, Sascha Einsele, Hermann Durie, Brian Wirk, Baldeep Mona Musto, Pellegrino Hayden, Patrick Kaiser, Martin Miguel, Jesús San Bladé, Joan Rajkumar, S. Vincent Mateos, Maria Victoria . Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer Journal. 2021, 11(12) | |
dc.identifier.uri | http://hdl.handle.net/10852/92046 | |
dc.description.abstract | Abstract Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progress in the last decades. PCL deserves a prompt identification to start the most effective treatment for this ultra-high-risk disease. The aim of this position paper is to revisit the diagnosis of PCL according to the presence of circulating plasma cells in patients otherwise meeting diagnostic criteria of multiple myeloma. We could identify two retrospective series where the question about what number of circulating plasma cells in peripheral blood should be used for defining PCL. The presence of ≥5% circulating plasma cells in patients with MM had a similar adverse prognostic impact as the previously defined PCL. Therefore, PCL should be defined by the presence of 5% or more circulating plasma cells in peripheral blood smears in patients otherwise diagnosed with symptomatic multiple myeloma. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage | |
dc.type | Journal article | |
dc.creator.author | Fernández de Larrea, Carlos | |
dc.creator.author | Kyle, RA | |
dc.creator.author | Rosiñol, Laura | |
dc.creator.author | Paiva, Bruno | |
dc.creator.author | Engelhardt, Monika | |
dc.creator.author | Usmani, Saad | |
dc.creator.author | Caers, Jo | |
dc.creator.author | Gonsalves, Wilson | |
dc.creator.author | Schjesvold, Fredrik Hellem | |
dc.creator.author | Merlini, Giampaolo | |
dc.creator.author | Lentzch, Suzanne | |
dc.creator.author | Ocio, Enrique | |
dc.creator.author | Garderet, Laurent | |
dc.creator.author | Moreau, Philippe | |
dc.creator.author | Sonneveld, Pieter | |
dc.creator.author | Badros, Ashraf | |
dc.creator.author | Gahrton, Gösta | |
dc.creator.author | Goldschmidt, Hartmut | |
dc.creator.author | Tuchman, Sascha | |
dc.creator.author | Einsele, Hermann | |
dc.creator.author | Durie, Brian | |
dc.creator.author | Wirk, Baldeep Mona | |
dc.creator.author | Musto, Pellegrino | |
dc.creator.author | Hayden, Patrick | |
dc.creator.author | Kaiser, Martin | |
dc.creator.author | Miguel, Jesús San | |
dc.creator.author | Bladé, Joan | |
dc.creator.author | Rajkumar, S. Vincent | |
dc.creator.author | Mateos, Maria Victoria | |
cristin.unitcode | 185,53,49,11 | |
cristin.unitname | Avdeling for blodsykdommer | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1998207 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Blood Cancer Journal&rft.volume=11&rft.spage=&rft.date=2021 | |
dc.identifier.jtitle | Blood Cancer Journal | |
dc.identifier.volume | 11 | |
dc.identifier.issue | 12 | |
dc.identifier.pagecount | 0 | |
dc.identifier.doi | https://doi.org/10.1038/s41408-021-00587-0 | |
dc.identifier.urn | URN:NBN:no-94640 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 2044-5385 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/92046/1/Primary%2Bplasma%2Bcell%2Bleukemia%2Bconsensus%2Bdefinition%2Bby%2Bthe%2BInternational%2BMyeloma%2BWorking%2BGroup%2Baccording%2Bto%2Bperipheral%2Bblood%2Bplasma%2Bcell%2Bpercentage.pdf | |
dc.type.version | PublishedVersion | |
cristin.articleid | 192 | |